App-Quantinova.ai

Impact of serum leptin and adiponectin levels on the development of brain infarcts in patients with mild cognitive impairment and Alzheimer's disease

Grazia Daniela Femminella - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

Midlife proteome-wide analysis identifies plasma biomarkers for 25-year dementia risk linked to diverse pathophysiology

Gabriela Gomez - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

N/A

- Derivation of cut-offs for plasma neurofilament light in clinical routine using healthy subjects aged between 5-90

Joel Simrén - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

- Blood plasma biomarkers improve prediction accuracy over and above genetic predictors of Alzheimer’s disease

Joshua O Stevenson-Hoare - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Impact of the COVID-19 pandemic on early career dementia researchers: a global online survey

C. Elizabeth Shaaban - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Dementia

N/A

Alzheimer’s disease and other dementias in China: secular trend in disease burden from 1990 to 2019 and projections to 2030

Jiawei Geng - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

- Geographical variation in dementia: systematic review with meta-analysis

Graciela Muniz‐Terrera - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Alzheimer-like biomarker heterogeneity in a preclinical elderly birth cohort: Insight46

Mar Estarellas Garcia - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Association between A/T/N profiles and mortality in patients with cognitive disorders.

Mélina Régy - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Brain regions with higher noradrenergic innervation show greater vulnerability to degeneration in preclinicial Alzheimer’s disease

Lena Haag - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

No added value of Sex and APOE*4 stratification for Alzheimer’s Disease Genetic Risk Scores

Michael E Belloy - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Air pollution has a more deleterious effect on Alzheimer’s disease biomarkers in genetic predisposition to larger hippocampal volumes

Natalia Vilor-Tejedor - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Biological Brain Age Prediction Using Machine Learning on Structural Neuroimaging Data: Multi-Cohort Validation Against Biomarkers of Alzheimer’s Disease and Neurodegeneration

Irene Cumplido-Mayoral - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

White matter hyperintensities

Mofezolac

Describing biomarkers for Alzheimer’s disease: Localization of amyloid-β in the retina

Sieun Lee - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

Glutamine

Longitudinal Blood Biomarker Trajectories in Preclinical Alzheimer’s Disease

Yara Yakoub - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

[18F]NAV4694

AT(N) Biomarker Profiles and Alzheimer’s Disease Clinical Status and Memory in Adults with Down syndrome

Sigan L Hartley - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Mild cognitive impairment

AV-1451

Composite SUVR: a new method for boosting Alzheimer’s disease monitoring and diagnostic performance, applied to tau PET

Isaac Llorente Saguer - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

AV-1451

A stratified approach to identifying and investigating neonatal seizures: a service evaluation

Lydia E. Roberts - Pediatric Academic Societies (PAS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Neonatal seizures

N/A

"Less invasive surfactant administration to preterm infants on high-flow nasal therapyâ?

Sanja Zivanovic - Pediatric Academic Societies (PAS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

MDT010

"Mildâ? Hypoxic Ischemic Encephalopathy and Therapeutic Hypothermia: an international survey of clinician practice

MANI SINGLA - Pediatric Academic Societies (PAS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypoxic-ischemic encephalopathy

N/A

Filters

45280 Abstracts